BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang W, Luo HS, Yu BP. Expression of NF-κB and human telomerase reverse transcriptase in gastric cancer and precancerous lesions. World J Gastroenterol 2004; 10(2): 177-181 [PMID: 14716817 DOI: 10.3748/wjg.v10.i2.177] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 34] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Huang KH, Lan YT, Fang WL, Chen JH, Lo SS, Li AF, Chiou SH, Wu CW, Shyr YM. The correlation between miRNA and lymph node metastasis in gastric cancer. Biomed Res Int 2015;2015:543163. [PMID: 25688358 DOI: 10.1155/2015/543163] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
2 Sokolova O, Naumann M. NF-κB Signaling in Gastric Cancer.Toxins (Basel). 2017;9:119. [PMID: 28350359 DOI: 10.3390/toxins9040119] [Cited by in Crossref: 89] [Cited by in F6Publishing: 88] [Article Influence: 17.8] [Reference Citation Analysis]
3 Peng L, Xie YF, Wang CG, Wu HG, Liu M, Wang YD, Ma FQ, Chang XR, Yang ZB. MOXIBUSTION ALLEVIATES GASTRIC PRECANCEROUS LESIONS IN RATS BY PROMOTING CELL APOPTOSIS AND INHIBITING PROLIFERATION-RELATED ONCOGENES. Afr J Tradit Complement Altern Med 2017;14:148-60. [PMID: 28573231 DOI: 10.21010/ajtcam.v14i2.16] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
4 Gigek CO, Leal MF, Silva PNO, Lisboa LCF, Lima EM, Calcagno DQ, Assumpção PP, Burbano RR, Smith MDAC. hTERT methylation and expression in gastric cancer. Biomarkers 2009;14:630-6. [DOI: 10.3109/13547500903225912] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
5 Xie D, Sun MY. Mechanism of action of NF-κB related cell signaling pathways in progression of gastritis to carcinoma. Shijie Huaren Xiaohua Zazhi 2022; 30(6): 255-259 [DOI: 10.11569/wcjd.v30.i6.255] [Reference Citation Analysis]
6 Yu Y, Li Q, Zhu Z. NF-κB as a molecular target in adjuvant therapy of gastrointestinal carcinomas. European Journal of Surgical Oncology (EJSO) 2005;31:386-92. [DOI: 10.1016/j.ejso.2004.10.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
7 Santhi WS, Sebastian P, Varghese BT, Prakash O, Pillai MR. NF-kappaB and COX-2 during oral tumorigenesis and in assessment of minimal residual disease in surgical margins. Exp Mol Pathol 2006;81:123-30. [PMID: 16822500 DOI: 10.1016/j.yexmp.2006.05.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
8 Cao HJ, Fang Y, Zhang X, Chen WJ, Zhou WP, Wang H, Wang LB, Wu JM. Tumor metastasis and the reciprocal regulation of heparanase gene expression by nuclear factor kappa B in human gastric carcinoma tissue. World J Gastroenterol 2005; 11(6): 903-907 [PMID: 15682491 DOI: 10.3748/wjg.v11.i6.903] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
9 Palanissami G, Paul SFD. RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer—a Review. HORM CANC 2018;9:295-325. [DOI: 10.1007/s12672-018-0342-9] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 13.8] [Reference Citation Analysis]
10 Zuo QP, Liu SK, Li ZJ, Li B, Zhou YL, Guo R, Huang LH. NF-kappaB p65 modulates the telomerase reverse transcriptase in the HepG₂ hepatoma cell line. Eur J Pharmacol 2011;672:113-20. [PMID: 22008847 DOI: 10.1016/j.ejphar.2011.09.187] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
11 Brücher BL, Lang F, Jamall IS, Bandapalli OR. NF- κ B signaling and crosstalk during carcinogenesis. 4open 2019;2:13. [DOI: 10.1051/fopen/2019010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
12 Smolińska M, Grzanka D, Antosik P, Kasperska A, Neska-Długosz I, Jóźwicki J, Klimaszewska-Wiśniewska A. HER2, NF-κB, and SATB1 Expression Patterns in Gastric Cancer and Their Correlation with Clinical and Pathological Parameters. Dis Markers 2019;2019:6315936. [PMID: 31737131 DOI: 10.1155/2019/6315936] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Lü MH, Deng JQ, Cao YL, Fang DC, Zhang Y, Yang SM. Prognostic role of telomerase activity in gastric adenocarcinoma: A meta-analysis. Exp Ther Med 2012;3:728-34. [PMID: 22969960 DOI: 10.3892/etm.2012.471] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
14 Sikand K, Kaul D, Varma N. Receptor Ck-dependent signaling regulates hTERT gene transcription. BMC Cell Biol 2006;7. [DOI: 10.1186/1471-2121-7-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
15 Wang S, Tian L, Zeng Z, Zhang M, Wu K, Chen M, Fan D, Hu P, Sung JJ, Yu J. IkappaBalpha polymorphism at promoter region (rs2233408) influences the susceptibility of gastric cancer in Chinese. BMC Gastroenterol 2010;10:15. [PMID: 20132559 DOI: 10.1186/1471-230X-10-15] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
16 Leal MF, Calcagno DQ, Khayat AS, Silva TCR, Muniz JAPC, Assumpção PP, de Arruda Cardoso Smith M, Burbano RR. hTERT and TP53 deregulation in intestinal-type gastric carcinogenesis in non-human primates. Clin Exp Med 2013;13:221-4. [DOI: 10.1007/s10238-012-0195-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
17 Shi C, Sun L, Song Y. FEZF1-AS1: a novel vital oncogenic lncRNA in multiple human malignancies. Biosci Rep 2019;39:BSR20191202. [PMID: 31175144 DOI: 10.1042/BSR20191202] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
18 Cobler L, Mejías-Luque R, Garrido M, Pera M, Badia-Garrido E, de Bolós C. Activation of the NF-kB pathway downregulates TFF-1 in gastric carcinogenesis. Virchows Arch 2013;463:497-507. [PMID: 23942618 DOI: 10.1007/s00428-013-1469-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
19 Sheng R, Gu Z, Xie M. Epigallocatechin gallate, the major component of polyphenols in green tea, inhibits telomere attrition mediated cardiomyocyte apoptosis in cardiac hypertrophy. International Journal of Cardiology 2013;162:199-209. [DOI: 10.1016/j.ijcard.2011.07.083] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
20 Zhang Z, Ma J, Li N, Sun N, Wang C. Expression of Nuclear Factor-κB and Its Clinical Significance in Nonsmall-Cell Lung Cancer. The Annals of Thoracic Surgery 2006;82:243-8. [DOI: 10.1016/j.athoracsur.2006.01.049] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
21 Levidou G, Korkolopoulou P, Nikiteas N, Tzanakis N, Thymara I, Saetta AA, Tsigris C, Rallis G, Vlasis K, Patsouris E. Expression of Nuclear Factor κB in Human Gastric Carcinoma: Relationship with IκBa and Prognostic Significance. Virchows Archiv. 2007;450:519-527. [PMID: 17429689 DOI: 10.1007/s00428-007-0396-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
22 Li R, Ma T, Gu J, Liang X, Li S. Imbalanced network biomarkers for traditional Chinese medicine Syndrome in gastritis patients. Sci Rep. 2013;3:1543. [PMID: 23529020 DOI: 10.1038/srep01543] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 5.3] [Reference Citation Analysis]
23 Turkington RC, Purcell C, James CR, Millar J, Napier E, Law D, Gallagher R, Morris M, Wilson RH, Eatock MM. A phase I trial of bortezomib in combination with epirubicin, carboplatin and capecitabine (ECarboX) in advanced oesophagogastric adenocarcinoma. Invest New Drugs 2014;32:250-60. [PMID: 23665866 DOI: 10.1007/s10637-013-9970-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
24 Zou D, Xu L, Li H, Ma Y, Gong Y, Guo T, Jing Z, Xu X, Zhang Y. Role of abnormal microRNA expression in Helicobacter pylori associated gastric cancer. Crit Rev Microbiol 2019;45:239-51. [PMID: 30776938 DOI: 10.1080/1040841X.2019.1575793] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Chaithongyot S, Jantaree P, Sokolova O, Naumann M. NF-κB in Gastric Cancer Development and Therapy. Biomedicines 2021;9:870. [PMID: 34440074 DOI: 10.3390/biomedicines9080870] [Reference Citation Analysis]
26 Silva TC, Leal MF, Calcagno DQ, de Souza CR, Khayat AS, dos Santos NP, Montenegro RC, Rabenhorst SH, Nascimento MQ, Assumpção PP, de Arruda Cardoso Smith M, Burbano RR. hTERT, MYC and TP53 deregulation in gastric preneoplastic lesions. BMC Gastroenterol 2012;12:85. [PMID: 22768805 DOI: 10.1186/1471-230X-12-85] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
27 Hu Jian, Sun Li, Zhang Chong, Zhou XL. Expression of telomeric repeat binding factor 1 protein in nonsmall cell lung cancer with human telomerase reverse transcriptase positive. Int J Surg Pathol 2008;16:414-8. [PMID: 18397896 DOI: 10.1177/1066896908315755] [Reference Citation Analysis]
28 Zhang B, Ling T, Zhaxi P, Cao Y, Qian L, Zhao D, Kang W, Zhang W, Wang L, Xu G, Zou X. Proton pump inhibitor pantoprazole inhibits gastric cancer metastasis via suppression of telomerase reverse transcriptase gene expression. Cancer Letters 2019;452:23-30. [DOI: 10.1016/j.canlet.2019.03.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
29 Abdulamir AS, Hafidh RR, Mahdi LK, Al-jeboori T, Abubaker F. Investigation into the controversial association of Streptococcus gallolyticus with colorectal cancer and adenoma. BMC Cancer 2009;9:403. [PMID: 19925668 DOI: 10.1186/1471-2407-9-403] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
30 Ye S, Long YM, Rong J, Xie WR. Nuclear factor kappa B: A marker of chemotherapy for human stage IV gastric carcinoma. World J Gastroenterol 2008; 14(30): 4739-4744 [PMID: 18720533 DOI: 10.3748/wjg.14.4739] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
31 Cheng YB, Guo LP, Yao P, Ning XY, Aerken G, Fang DC. Telomerase and hTERT: Can they serve as markers for gastric cancer diagnosis? World J Gastroenterol 2014; 20(21): 6615-6619 [PMID: 24914385 DOI: 10.3748/wjg.v20.i21.6615] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
32 Kang Y, Zhang J, Sun P, Shang J. Circulating cell-free human telomerase reverse transcriptase mRNA in plasma and its potential diagnostic and prognostic value for gastric cancer. Int J Clin Oncol. 2013;18:478-486. [PMID: 22527847 DOI: 10.1007/s10147-012-0405-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
33 Hao Q, Zhang C, Gao Y, Wang S, Li J, Li M, Xue X, Li W, Zhang W, Zhang Y. FOXP3 inhibits NF-κB activity and hence COX2 expression in gastric cancer cells. Cell Signal. 2014;26:564-569. [PMID: 24308961 DOI: 10.1016/j.cellsig.2013.11.030] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
34 Sethi G, Sung B, Aggarwal BB. Nuclear factor-kappaB activation: from bench to bedside. Exp Biol Med (Maywood). 2008;233:21-31. [PMID: 18156302 DOI: 10.3181/0707-mr-196] [Cited by in Crossref: 301] [Cited by in F6Publishing: 140] [Article Influence: 21.5] [Reference Citation Analysis]
35 Cao HJ, Fang Y, Zhang X, Chen WJ, Zhou WP, Wang H, Wang LB, Wu JM. Tumor metastasis and the reciprocal regulation of heparanase gene expression by nuclear factor kappa B in human gastric carcinoma tissue. World J Gastroenterol. 2005;11:903-907. [PMID: 15682491 DOI: 10.1111/j.1365-2036.2005.02353.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]